These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26549579)

  • 21. Molecular biological investigations into the role of the NMDA receptor in the pathophysiology of schizophrenia.
    Catts SV; Ward PB; Lloyd A; Huang XF; Dixon G; Chahl L; Harper C; Wakefield D
    Aust N Z J Psychiatry; 1997 Feb; 31(1):17-26. PubMed ID: 9088482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients.
    Lavoie S; Murray MM; Deppen P; Knyazeva MG; Berk M; Boulat O; Bovet P; Bush AI; Conus P; Copolov D; Fornari E; Meuli R; Solida A; Vianin P; Cuénod M; Buclin T; Do KQ
    Neuropsychopharmacology; 2008 Aug; 33(9):2187-99. PubMed ID: 18004285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of the NR2A NMDA receptor subunit in the prefrontal cortex of rats reared in isolation.
    Turnock-Jones JJ; Jennings CA; Robbins MJ; Cluderay JE; Cilia J; Reid JL; Taylor A; Jones DN; Emson PC; Southam E
    Synapse; 2009 Oct; 63(10):836-46. PubMed ID: 19533626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities.
    Rujescu D; Bender A; Keck M; Hartmann AM; Ohl F; Raeder H; Giegling I; Genius J; McCarley RW; Möller HJ; Grunze H
    Biol Psychiatry; 2006 Apr; 59(8):721-9. PubMed ID: 16427029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
    Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
    Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A recently-discovered NMDA receptor gene, GRIN3B, is associated with duration mismatch negativity.
    Lin YT; Hsieh MH; Liu CC; Hwang TJ; Chien YL; Hwu HG; Liu CM
    Psychiatry Res; 2014 Aug; 218(3):356-8. PubMed ID: 24814139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia.
    Halene TB; Ehrlichman RS; Liang Y; Christian EP; Jonak GJ; Gur TL; Blendy JA; Dow HC; Brodkin ES; Schneider F; Gur RC; Siegel SJ
    Genes Brain Behav; 2009 Oct; 8(7):661-75. PubMed ID: 19563516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mismatch negativity in bipolar disorder: A neurophysiological biomarker of intermediate effect?
    Hermens DF; Chitty KM; Kaur M
    Schizophr Res; 2018 Jan; 191():132-139. PubMed ID: 28450056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia.
    Javitt DC; Lee M; Kantrowitz JT; Martinez A
    Schizophr Res; 2018 Jan; 191():51-60. PubMed ID: 28666633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormalities of the NMDA Receptor and Associated Intracellular Molecules in the Thalamus in Schizophrenia and Bipolar Disorder.
    Clinton SM; Meador-Woodruff JH
    Neuropsychopharmacology; 2004 Jul; 29(7):1353-62. PubMed ID: 15054476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphism analysis of the upstream region of the human N-methyl-D-aspartate receptor subunit NR1 gene (GRIN1): implications for schizophrenia.
    Tani A; Kikuta R; Itoh K; Joo A; Shibata H; Ninomiya H; Tashiro N; Fukumaki Y
    Schizophr Res; 2002 Nov; 58(1):83-6. PubMed ID: 12363394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased levels of D-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia.
    Errico F; Napolitano F; Squillace M; Vitucci D; Blasi G; de Bartolomeis A; Bertolino A; D'Aniello A; Usiello A
    J Psychiatr Res; 2013 Oct; 47(10):1432-7. PubMed ID: 23835041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NMDA NR1 subunit mRNA and glutamate NMDA-sensitive binding are differentially affected in the striatum and pre-frontal cortex of Parkinson's disease patients.
    Meoni P; Bunnemann BH; Kingsbury AE; Trist DG; Bowery NG
    Neuropharmacology; 1999 May; 38(5):625-33. PubMed ID: 10340300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postsynaptic density levels of the NMDA receptor NR1 subunit and PSD-95 protein in prefrontal cortex from people with schizophrenia.
    Catts VS; Derminio DS; Hahn CG; Weickert CS
    NPJ Schizophr; 2015; 1():15037. PubMed ID: 27336043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the hippocampal NMDA receptor GluN1 subunit and its splicing isoforms in schizophrenia: postmortem study.
    Vrajová M; Stastný F; Horácek J; Lochman J; Serý O; Peková S; Klaschka J; Höschl C
    Neurochem Res; 2010 Jul; 35(7):994-1002. PubMed ID: 20204507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of D-serine and glycine transporters in the prefrontal cortex and cerebellum in schizophrenia.
    Burnet PW; Hutchinson L; von Hesling M; Gilbert EJ; Brandon NJ; Rutter AR; Hutson PH; Harrison PJ
    Schizophr Res; 2008 Jul; 102(1-3):283-94. PubMed ID: 18400471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late deviance detection in rats is reduced, while early deviance detection is augmented by the NMDA receptor antagonist MK-801.
    Harms L; Fulham WR; Todd J; Meehan C; Schall U; Hodgson DM; Michie PT
    Schizophr Res; 2018 Jan; 191():43-50. PubMed ID: 28385587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frontal Glutamate and γ-Aminobutyric Acid Levels and Their Associations With Mismatch Negativity and Digit Sequencing Task Performance in Schizophrenia.
    Rowland LM; Summerfelt A; Wijtenburg SA; Du X; Chiappelli JJ; Krishna N; West J; Muellerklein F; Kochunov P; Hong LE
    JAMA Psychiatry; 2016 Feb; 73(2):166-74. PubMed ID: 26720179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic data supporting the NMDA glutamate receptor hypothesis for schizophrenia.
    Schwartz TL; Sachdeva S; Stahl SM
    Curr Pharm Des; 2012; 18(12):1580-92. PubMed ID: 22280435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketamine Administration During the Second Postnatal Week Alters Synaptic Properties of Fast-Spiking Interneurons in the Medial Prefrontal Cortex of Adult Mice.
    Jeevakumar V; Kroener S
    Cereb Cortex; 2016 Mar; 26(3):1117-29. PubMed ID: 25477370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.